SARS-COV-2-SPECIFIC T CELLS AND METHODS OF TREATMENT USING THEM

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240216507A1
SERIAL NO

17907180

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention pertains to a method for preventing or treating SARS-CoV-2 infection by administering SARS-CoV-2 specific T cells which recognize particular peptide epitopes in SARS-CoV-2 spike (S), nucleocapsid (N), membrane, and envelope proteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHILDREN'S NATIONAL MEDICAL CENTER111 MICHIGAN AVENUE NW WASHINGTON DC 20010

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ABRAHAM, Allistair Washington, US 1 0
BOLLARD, Catherine Washington, US 9 2
CRUZ, Conrad Russell Y Washington, US 12 5
HANLEY, Patrick Washington, US 26 467
KELLER, Michael Washington, US 148 1095
LAZARSKI, Chris Washington, US 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation